Taking a small step back in time, the lipid management guidelines issued by the American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) earlier in 2017 re-affirm the use of LDL-C targets to help minimize cardiovascular risk in all patients, and especially those with type 2 diabetes (T2DM). The guideline includes a first-ever "extreme risk" patient category for whom an LDL-C level of < 55 mg/dL is advised. More discussion around targets vs no targets is ensured.
Review the topline recommendations in the slides above.
Source: Garber AJ, Abrahamson MJ, Barzilay JI, et al. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm. 2017 Executive Summary. Endocr Pract. 2017;23:207-238. doi: 10.4158/EP161682.CS. Epub 2017 Jan 17.